Weiping Yu

2.4k total citations · 2 hit papers
11 papers, 1.8k citations indexed

About

Weiping Yu is a scholar working on Psychiatry and Mental health, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, Weiping Yu has authored 11 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 6 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Pharmacology. Recurrent topics in Weiping Yu's work include Schizophrenia research and treatment (8 papers), Diabetes Treatment and Management (4 papers) and Diabetes Management and Research (3 papers). Weiping Yu is often cited by papers focused on Schizophrenia research and treatment (8 papers), Diabetes Treatment and Management (4 papers) and Diabetes Management and Research (3 papers). Weiping Yu collaborates with scholars based in Netherlands, United States and Belgium. Weiping Yu's co-authors include Marc D. Binder, Ruud van Winkel, Christoph U. Correll, Johan Detraux, Kim Sweers, Alex J. Mitchell, Davy Vancampfort, Martien Wampers, Peter Manu and Stephan Claes and has published in prestigious journals such as PLoS ONE, Schizophrenia Bulletin and Nature Reviews Endocrinology.

In The Last Decade

Weiping Yu

11 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

2011 833 citations Marc D. Binder, Johan Detraux et al. Nature Reviews Endocrinology profile →
Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders—A Systematic Review and Meta-Analysis

2011 777 citations Alex J. Mitchell, Davy Vancampfort et al. Schizophrenia Bulletin profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weiping Yu Netherlands	8	1.2k	483	467	213	205	11	1.8k
Kim Sweers Belgium	20	1.4k 1.2×	469 1.0×	640 1.4×	199 0.9×	219 1.1×	25	2.2k
Jonathan M. Meyer United States	10	1.4k 1.2×	679 1.4×	550 1.2×	206 1.0×	203 1.0×	13	1.9k
Chris Bushe United Kingdom	26	1.3k 1.1×	409 0.8×	295 0.6×	100 0.5×	113 0.6×	53	1.9k
Tony Cohn Canada	19	997 0.8×	472 1.0×	588 1.3×	73 0.3×	140 0.7×	34	1.5k
Peter Manu United States	29	2.2k 1.9×	556 1.2×	425 0.9×	135 0.6×	360 1.8×	108	3.2k
Martina Ryan Ireland	8	766 0.6×	440 0.9×	382 0.8×	235 1.1×	121 0.6×	10	1.3k
J. Peuskens Belgium	29	1.7k 1.4×	408 0.8×	298 0.6×	126 0.6×	119 0.6×	87	2.6k
D Van Eyck Belgium	16	1.1k 0.9×	663 1.4×	371 0.8×	80 0.4×	110 0.5×	33	1.4k
Jingping Zhao China	18	749 0.6×	255 0.5×	322 0.7×	167 0.8×	73 0.4×	65	1.7k
Clemente García‐Rizo Spain	29	1.3k 1.1×	410 0.8×	435 0.9×	526 2.5×	65 0.3×	105	2.4k

Countries citing papers authored by Weiping Yu

Since Specialization

Citations

This map shows the geographic impact of Weiping Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiping Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiping Yu more than expected).

Fields of papers citing papers by Weiping Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiping Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiping Yu. The network helps show where Weiping Yu may publish in the future.

Co-authorship network of co-authors of Weiping Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Weiping Yu. A scholar is included among the top collaborators of Weiping Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiping Yu. Weiping Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Mitchell, Alex J., Davy Vancampfort, Peter Manu, et al.. (2019). Which clinical and biochemical predictors should be used to screen for diabetes in patients with serious mental illness receiving antipsychotic medication? A large observational study. PLoS ONE. 14(9). e0210674–e0210674. 3 indexed citations

Schependom, Jeroen Van, et al.. (2015). Do Advanced Statistical Techniques Really Help in the Diagnosis of the Metabolic Syndrome in Patients Treated With Second-Generation Antipsychotics?. The Journal of Clinical Psychiatry. 76(10). e1292–e1299. 5 indexed citations

Yu, Weiping, et al.. (2013). CNR1 Gene and Risk of the Metabolic Syndrome in Patients With Schizophrenia. Journal of Clinical Psychopharmacology. 33(2). 186–192. 25 indexed citations

Binder, Marc D., Weiping Yu, Johan Detraux, et al.. (2012). Body Weight and Metabolic Adverse Effects of Asenapine, Iloperidone, Lurasidone and Paliperidone in the Treatment of Schizophrenia and Bipolar Disorder. CNS Drugs. 26(9). 733–759. 119 indexed citations

Manu, Peter, Christoph U. Correll, Martien Wampers, et al.. (2012). Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone. Schizophrenia Research. 143(2-3). 358–362. 22 indexed citations

Manu, Peter, Christoph U. Correll, Martien Wampers, et al.. (2012). Prediabetic increase in hemoglobin A1c compared with impaired fasting glucose in patients receiving antipsychotic drugs. European Neuropsychopharmacology. 23(3). 205–211. 10 indexed citations

Yu, Weiping, et al.. (2012). Poster #99 CNR1 AND RISK OF THE METABOLIC SYNDROME IN PATIENTS WITH SCHIZOPHRENIA. Schizophrenia Research. 136. S126–S127. 1 indexed citations

Mitchell, Alex J., Davy Vancampfort, Kim Sweers, et al.. (2011). Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders—A Systematic Review and Meta-Analysis. Schizophrenia Bulletin. 39(2). 306–318. 777 indexed citations breakdown →

Binder, Marc D., Johan Detraux, Ruud van Winkel, Weiping Yu, & Christoph U. Correll. (2011). Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nature Reviews Endocrinology. 8(2). 114–126. 833 indexed citations breakdown →

10.

Zhang, Hua, Weiping Yu, Lizhe An, et al.. (2008). Origin and evolution of two Yugur sub-clans in Northwest China: a case study in paternal genetic landscape. Annals of Human Biology. 35(2). 198–211. 11 indexed citations

11.

An, Lizhe, Xunling Wang, Wei Shao, et al.. (2007). Testing the hypothesis of an ancient Roman soldier origin of the Liqian people in northwest China: a Y-chromosome perspective. Journal of Human Genetics. 52(7). 584–591. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact